BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ER, estrogen receptor AND Treatment
432 results:

  • 1. Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report.
    Chitnis SD; Seim NB; Kendra K
    J Med Case Rep; 2024 May; 18(1):257. PubMed ID: 38778387
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phenformin activates ER stress to promote autophagic cell death via NIBAN1 and DDIT4 in oral squamous cell carcinoma independent of AMPK.
    Zhuang D; Wang S; Deng H; Shi Y; Liu C; Leng X; Zhang Q; Bai F; Zheng B; Guo J; Wu X
    Int J Oral Sci; 2024 May; 16(1):35. PubMed ID: 38719825
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk factors for lymph node metastasis in superficial esophageal squamous cell carcinoma.
    Yu YB
    World J Gastroenterol; 2024 Apr; 30(13):1810-1814. PubMed ID: 38659479
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction.
    Thi Thanh Nguyen N; Yoon Lee S
    Biochem Pharmacol; 2024 Jun; 224():116221. PubMed ID: 38641308
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review.
    Luo R; Wang Y; Li R; Ma Y; Chen H; Zhang J; Shen J
    BMC Oral Health; 2024 Apr; 24(1):469. PubMed ID: 38632580
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy of endoscopic surveillance for pharyngeal mucosa during endoscopic resection for pharyngeal carcinoma: a multicenter prospective study.
    Kimura Y; Shimizu Y; Taniguchi M; Ito S; Dobashi A; Goda K; Nishimura Y; Yamamoto K; Ichihara S; Watanabe A
    Surg Endosc; 2024 May; 38(5):2497-2504. PubMed ID: 38466423
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Exposure-Response Relationships for Pralsetinib in Patients with RET-Altered Thyroid cancer or RET Fusion-Positive Nonsmall Cell Lung cancer.
    Kassir N; McDougall D; Kuruvilla D; Kim S; Kumar S; Rahman A; Ruf T; Cheeti S; Ankrom W
    J Clin Pharmacol; 2024 Jun; 64(6):685-696. PubMed ID: 38337106
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Amlodipine inhibits the proliferation and migration of esophageal carcinoma cells through the induction of endoplasmic reticulum stress.
    Chen YM; Yang WQ; Gu CW; Fan YY; Liu YZ; Zhao BS
    World J Gastroenterol; 2024 Jan; 30(4):367-380. PubMed ID: 38313237
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effects of postoperative antioxidants on the salivary glands in patients with thyroid cancer undergoing radioactive iodine-131 treatment.
    Tong H; Yue R; Fang J; Li X; Yang S; Hou Y; Wang R; Zhang B; Liu H; Wu Z; Cheng Y
    Nucl Med Commun; 2024 Apr; 45(4):312-320. PubMed ID: 38312062
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect.
    Li X; Zheng H; Ma C; Ji Y; Wang X; Sun D; Meng Z; Zheng W
    Front Endocrinol (Lausanne); 2023; 14():1307325. PubMed ID: 38298190
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An ESR1-Related Gene Signature Identifies head and neck Squamous Cell Carcinoma with Imputed Susceptibility to Endocrine Therapy.
    Almouhanna F; Hess J
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279245
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
    Cho H; Abe S; Nonaka S; Suzuki H; Yoshinaga S; Okuma K; Yamamoto S; Daiko H; Kato K; Sekine S; Boku N; Saito Y
    Dis Esophagus; 2024 Apr; 37(5):. PubMed ID: 38266034
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
    Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
    Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
    Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
    Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Acetylshikonin induces apoptosis through the endoplasmic reticulum stress-activated PERK/eIF
    Yuan YJ; Liu S; Yang H; Xu JL; Zhai J; Jiang HM; Sun B
    J Cell Mol Med; 2024 Jan; 28(1):e18030. PubMed ID: 37929884
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients.
    Gambale C; Prete A; Contartese L; Torregrossa L; Bianchi F; Molinaro E; Materazzi G; Elisei R; Matrone A
    Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855417
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. BRAF
    Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
    Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
    Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
    Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway.
    Yuan H; Zhao Z; Xu J; Zhang R; Ma L; Han J; Zhao W; Guo M; Song Y
    J Exp Clin Cancer Res; 2023 Sep; 42(1):249. PubMed ID: 37752569
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. estrogen receptor β affects hypoxia response in colorectal cancer cells.
    Rawłuszko-Wieczorek AA; Lipowicz J; Nowacka M; Ostrowska K; Pietras P; Blatkiewicz M; Ruciński M; Jagodziński PP; Nowicki M
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166894. PubMed ID: 37748565
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.